本页面由Tiger Trade Technology Pte. Ltd.提供服务

ORUKA THERAPEUTICS INC

78.19
-2.1600-2.69%
盘后:78.400.2100+0.27%19:55 EDT
成交量:50.07万
成交额:3,953.11万
市值:51.77亿
市盈率:-38.63
高:80.19
开:79.47
低:78.18
收:80.35
52周最高:115.52
52周最低:24.46
股本:6,620.97万
流通股本:5,688.40万
量比:0.51
换手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):-2.0242
每股收益(LYR):-1.8483
净资产收益率:-18.23%
总资产收益率:-12.95%
市净率:4.66
市盈率(LYR):-42.30

数据加载中...

2025/03/06

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/05

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/22

SEC问询函

Form CORRESP - Correspondence
2024/11/21

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/23

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/04

重要事件披露

Form 8-K - Current report
2024/09/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/14

重要事件披露

Form 8-K - Current report
2024/09/07

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/05

重要事件披露

Form 8-K - Current report
2024/08/27

重要事件披露

Form 8-K - Current report